FDA Drug Application (203414) for KAZANO by TAKEDA PHARMS USA

Back to FDA Applications sponsored by TAKEDA PHARMS USA

Application Number203414
Product Number001
FormTABLET;ORAL
DosageEQ 12.5MG BASE;500MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameKAZANO
Active IngredientALOGLIPTIN BENZOATE; METFORMIN HYDROCHLORIDE



Back to FDA Applications sponsored by TAKEDA PHARMS USA

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.